These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9698310)

  • 1. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
    Traynelis SF; Burgess MF; Zheng F; Lyuboslavsky P; Powers JL
    J Neurosci; 1998 Aug; 18(16):6163-75. PubMed ID: 9698310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
    Masuko T; Kashiwagi K; Kuno T; Nguyen ND; Pahk AJ; Fukuchi J; Igarashi K; Williams K
    Mol Pharmacol; 1999 Jun; 55(6):957-69. PubMed ID: 10347236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor.
    Choi YB; Lipton SA
    Neuron; 1999 May; 23(1):171-80. PubMed ID: 10402203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.
    Williams K
    Neurosci Lett; 1996 Aug; 215(1):9-12. PubMed ID: 8880741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC; Potthoff WK; Aizenman E
    J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis rescues spermine and Zn2+ potentiation of recombinant NMDA receptors.
    Zheng X; Zhang L; Durand GM; Bennett MV; Zukin RS
    Neuron; 1994 Apr; 12(4):811-8. PubMed ID: 8161453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
    Kashiwagi K; Fukuchi J; Chao J; Igarashi K; Williams K
    Mol Pharmacol; 1996 Jun; 49(6):1131-41. PubMed ID: 8649353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
    Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
    Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity zinc inhibition of NMDA NR1-NR2A receptors.
    Paoletti P; Ascher P; Neyton J
    J Neurosci; 1997 Aug; 17(15):5711-25. PubMed ID: 9221770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
    Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
    Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL; Larson HC; Morrisett RA; Monaghan DT
    Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.
    Igarashi K; Shirahata A; Pahk AJ; Kashiwagi K; Williams K
    J Pharmacol Exp Ther; 1997 Nov; 283(2):533-40. PubMed ID: 9353367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines.
    Traynelis SF; Hartley M; Heinemann SF
    Science; 1995 May; 268(5212):873-6. PubMed ID: 7754371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
    Williams K; Zappia AM; Pritchett DB; Shen YM; Molinoff PB
    Mol Pharmacol; 1994 May; 45(5):803-9. PubMed ID: 8190097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.
    Kostakis E; Jang MK; Russek SJ; Gibbs TT; Farb DH
    J Neurochem; 2011 Nov; 119(3):486-96. PubMed ID: 21883211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors.
    Chao J; Seiler N; Renault J; Kashiwagi K; Masuko T; Igarashi K; Williams K
    Mol Pharmacol; 1997 May; 51(5):861-71. PubMed ID: 9145925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
    Chen N; Moshaver A; Raymond LA
    Mol Pharmacol; 1997 Jun; 51(6):1015-23. PubMed ID: 9187268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Block and modulation of N-methyl-D-aspartate receptors by polyamines and protons: role of amino acid residues in the transmembrane and pore-forming regions of NR1 and NR2 subunits.
    Kashiwagi K; Pahk AJ; Masuko T; Igarashi K; Williams K
    Mol Pharmacol; 1997 Oct; 52(4):701-13. PubMed ID: 9380034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition.
    Zhang L; Zheng X; Paupard MC; Wang AP; Santchi L; Friedman LK; Zukin RS; Bennett MV
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10883-7. PubMed ID: 7971977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.